Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Prognostically important molecular markers in cytogenetically normal acute myeloid leukemia.

Lin TL, Smith BD.

Am J Med Sci. 2011 May;341(5):404-8. doi: 10.1097/MAJ.0b013e318201109d. Review.

PMID:
21522052
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics.

Gaidzik V, Döhner K.

Semin Oncol. 2008 Aug;35(4):346-55. doi: 10.1053/j.seminoncol.2008.04.005. Review.

PMID:
18692685
[PubMed - indexed for MEDLINE]
3.

Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics.

Marcucci G, Mrózek K, Bloomfield CD.

Curr Opin Hematol. 2005 Jan;12(1):68-75. Review.

PMID:
15604894
[PubMed - indexed for MEDLINE]
4.

[Advances of study on prognostic factors of molecular biology in acute myeloid leukemia with normal cytogenetics].

Han TJ, Xu XP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):1063-8. Review. Chinese.

PMID:
20723330
[PubMed - indexed for MEDLINE]
5.

Mutational landscape of AML with normal cytogenetics: biological and clinical implications.

Martelli MP, Sportoletti P, Tiacci E, Martelli MF, Falini B.

Blood Rev. 2013 Jan;27(1):13-22. doi: 10.1016/j.blre.2012.11.001. Epub 2012 Dec 20. Review.

PMID:
23261068
[PubMed - indexed for MEDLINE]
6.

Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis.

Port M, Böttcher M, Thol F, Ganser A, Schlenk R, Wasem J, Neumann A, Pouryamout L.

Ann Hematol. 2014 Aug;93(8):1279-86. doi: 10.1007/s00277-014-2072-6. Epub 2014 May 7. Review.

PMID:
24801015
[PubMed - indexed for MEDLINE]
7.

Acute myeloid leukemia with normal cytogenetics.

Mawad R, Estey EH.

Curr Oncol Rep. 2012 Oct;14(5):359-68. doi: 10.1007/s11912-012-0252-x. Review.

PMID:
22806102
[PubMed - indexed for MEDLINE]
8.

Acute myeloid leukemia: 2013 update on risk-stratification and management.

Estey EH.

Am J Hematol. 2013 Apr;88(4):318-27. doi: 10.1002/ajh.23404. Review.

PMID:
23526416
[PubMed - indexed for MEDLINE]
9.

Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics.

Gregory TK, Wald D, Chen Y, Vermaat JM, Xiong Y, Tse W.

J Hematol Oncol. 2009 Jun 2;2:23. doi: 10.1186/1756-8722-2-23. Review.

PMID:
19490647
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Clinical implications of molecular genetic aberrations in acute myeloid leukemia.

Scholl S, Fricke HJ, Sayer HG, Höffken K.

J Cancer Res Clin Oncol. 2009 Apr;135(4):491-505. doi: 10.1007/s00432-008-0524-x. Epub 2009 Jan 6. Review.

PMID:
19125300
[PubMed - indexed for MEDLINE]
11.

Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics.

Cagnetta A, Adamia S, Acharya C, Patrone F, Miglino M, Nencioni A, Gobbi M, Cea M.

Leuk Res. 2014 Jun;38(6):649-59. doi: 10.1016/j.leukres.2014.03.006. Epub 2014 Mar 18. Review.

PMID:
24726781
[PubMed - indexed for MEDLINE]
12.

Clinically useful prognostic factors in acute myeloid leukemia.

Ferrara F, Palmieri S, Leoni F.

Crit Rev Oncol Hematol. 2008 Jun;66(3):181-93. Epub 2007 Nov 8. Review.

PMID:
17996460
[PubMed - indexed for MEDLINE]
13.

New prognostic markers in acute myeloid leukemia: perspective from the clinic.

Foran JM.

Hematology Am Soc Hematol Educ Program. 2010;2010:47-55. doi: 10.1182/asheducation-2010.1.47. Review.

PMID:
21239770
[PubMed - indexed for MEDLINE]
Free Article
14.

Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.

Baldus CD, Bullinger L.

Semin Oncol. 2008 Aug;35(4):356-64. doi: 10.1053/j.seminoncol.2008.04.006. Review.

PMID:
18692686
[PubMed - indexed for MEDLINE]
15.

Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.

Ghanem H, Tank N, Tabbara IA.

Am J Hematol. 2012 Jan;87(1):69-77. doi: 10.1002/ajh.22197. Epub 2011 Nov 10. Review.

PMID:
22072438
[PubMed - indexed for MEDLINE]
16.

Prognostic factors in AML in relation to (ab)normal karyotype.

Stone RM.

Best Pract Res Clin Haematol. 2009 Dec;22(4):523-8. doi: 10.1016/j.beha.2009.07.003. Review.

PMID:
19959103
[PubMed - indexed for MEDLINE]
17.

Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experience and the review of the literature.

Krstovski N, Tosic N, Janic D, Dokmanovic L, Kuzmanovic M, Spasovski V, Pavlovic S.

Med Oncol. 2010 Sep;27(3):640-5. doi: 10.1007/s12032-009-9261-5. Epub 2009 Jun 26. Review.

PMID:
19557552
[PubMed - indexed for MEDLINE]
18.

Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.

Marcucci G, Haferlach T, Döhner H.

J Clin Oncol. 2011 Feb 10;29(5):475-86. doi: 10.1200/JCO.2010.30.2554. Epub 2011 Jan 10. Review. Erratum in: J Clin Oncol. 2011 May 1;29(13):1798.

PMID:
21220609
[PubMed - indexed for MEDLINE]
19.

Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.

Baldus CD, Mrózek K, Marcucci G, Bloomfield CD.

Br J Haematol. 2007 Jun;137(5):387-400. Review.

PMID:
17488484
[PubMed - indexed for MEDLINE]
20.

Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers.

Walker AR, Marcucci G.

J Natl Compr Canc Netw. 2014 Apr;12(4):527-34. Review.

PMID:
24717571
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk